CLOs on the Move

ProSomnus

www.prosomnus.com

 
ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.prosomnus.com
  • 5675 Gibraltar Drive
    Pleasanton, CA USA 94588
  • Phone: 844.537.5337

Executives

Name Title Contact Details

Similar Companies

Ophthonix

Ophthonix is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hygenia

Hygenia is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.

Regal Medical Group

Regal Medical Group is dedicated to delivering high quality of care with an emphasis of continuously improving service quality. Some of the benefits of being a Regal Provider are the tools and support we give the providers to effectively care for the

Iota Biosciences

Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning `neural-dust` technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.